Evidence map›Paper›PMID 37919892›Full record

ArticleKidney research and clinical practice2025

Target blood pressure in Korean hemodialysis patients for optimal survival.

Ji Eun Kim, Yun Jin Choi, Soon-Young Hwang, Hyeon Seok Hwang, Kyung Hwan Jeong, Eunjung Cho, Shin Young Ahn, Young Joo Kwon, Ju-Young Moon, Gang-Jee Ko

Open access · diamondAbstract read
In one paragraph

Article in Kidney research and clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ji Eun KimDepartment of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Yun Jin ChoiBiomedical Research Institute, Korea University Guro Hospital, Seoul, Republic of Korea.
Soon-Young HwangDepartment of Biostatistics, Korea University College of Medicine, Seoul, Republic of Korea.
Hyeon Seok HwangDepartment of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Kyung Hwan JeongDepartment of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Eunjung ChoDepartment of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Shin Young AhnDepartment of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Young Joo KwonDepartment of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Ju-Young MoonDepartment of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Gang-Jee KoDepartment of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Korea University · KRKyung Hee University · KRKorea University Medical Center · KR

Funding

Ministry of Health and Welfare H19C0481Ministry of Health and Welfare HC19C0041
6 · The paper itself

Abstract

backgroundHypertension is a major cardiovascular risk factor in hemodialysis patients. This study identified the optimal blood pressure (BP) target for Korean hemodialysis patients using the Korean Renal Dialysis System (KORDS) dataset from the Korean Society of Nephrology and a pooled analysis for previous studies.

methodsHemodialysis patients were classified according to their systolic (SBP) and diastolic BP (DBP) at intervals of 20 and 10 mmHg, respectively. As a primary and secondary outcome, all-cause mortality and cardiovascular mortality were evaluated. Subsequently, pooled analysis with previous literatures was performed.

resultsAmong 70,607 patients, 13,708 (19.4%) died in 2,426 days (interquartile range, 1,256-4,075 days). Mean SBP and DBP were 143.0 ± 19.6 and 78.5 ± 12.0 mmHg. In multivariable Cox regression, the patients with SBP of <120 and ≥180 mmHg showed 1.10- and 1.12-times increased risk of all-cause mortality compared to SBP of 120-140 mmHg. Meanwhile, DBP showed no significant association. In subgroup analysis, patients aged <70 years and without diabetes had a U-shaped SBP-mortality association. Cardiovascular mortality was increased in SBP of ≥160 mmHg compared to 120-140 mmHg, but it was not in <120 mmHg. Pooled analysis with previous studies mostly showed elevated risk in SBP of <120 mmHg, but the risks in 140-160 and 160-180 mmHg were not consistent.

conclusionExtremely lowering BP (<120 mmHg) or uncontrolled hypertension (≥160 mmHg) should be avoided to optimize survival in Korean hemodialysis patients. Detailed analysis for patients with SBP of 120-160 mmHg should be studied further under uniform BP measurement, along with consideration of risk of intradialytic hypotension. Tailored recommendations regarding patient risk factors also should be considered.

Indexed as

Cardiovascular mortalityHospital mortalityHypertensionMortalityRenal dialysis

Identifiers

PMID37919892
PMCPMC11985311
OpenAlexW4388153560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.